Table 1

Details of included studies

Study	Type of study		Participants		Interventions		Cataract surgery
Burnett⁹	Randomised double masked.		Number randomised: 14		Topical 1% fenoprofen sodium v placebo four times daily for 8 weeks.		Aphakic eyes with chronic CMO.
Flach¹⁰	Randomised double masked.		Number randomised: 30 Outcome on 26		Topical 0.5% ketorolac tromethamine v placebo four times daily for 8 weeks.		Aphakic and pseudophakic eyes with chronic CMO.
Flach⁸	Randomised double masked, multicentre study.		Number randomised: 120 (61 to active treatment, 59 to placebo).		Topical 0.5% ketorolac tromethamine v placebo four times daily for 12 weeks.		Aphakic and pseudophakic eyes with chronic CMO.
Yanuzzi¹¹	Randomised double masked.		Number randomised: 20		Oral indomethacin 25 mg v placebo three times a day for 6 weeks.		Aphakic chronic CMO.
Flach⁵	Randomised double masked, crossover study.		Number randomised: 24, 22 followed up to 2 months.		Topical 0.5% ketorolac tromethamine v placebo four times daily for 4 weeks.		Aphakic and pseudophakic eyes with acute CMO.
Heier⁶	Randomised double masked.		Number randomised: 28, 26 completed the study.		One drop topical 0.5% ketorolac tromethamine and artificial tears v prednisolone acetate and one drop topical 0.5% ketorolac tromethamine and artificial tears v prednisolone acetate and combination four times daily for a maximum of 12 weeks. Treatment tapered earlier if CMO resolved.		Aphakic and pseudophakic eyes with acute CMO.
Rho⁷	Randomised un-masked.		Number randomised: 34		Topical 0.5% ketorolac tromethamine v topical 0.1% diclofenac sodium one drop four times daily.		Pseudophakic eyes with acute CMO.